Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
About this item
Full title
Author / Creator
Publisher
John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Objectives
The objective of this study is to investigate the association between the use of beta‐adrenergic antagonist atenolol and risk of pathologic upgrade in patients on active surveillance, considering growing literature implicating adrenergic innervation with disease progression mediated through beta‐adrenergic signalling.
Patients and...
Alternative Titles
Full title
Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f57ea34029494f88bb93cf79a944e62a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f57ea34029494f88bb93cf79a944e62a
Other Identifiers
ISSN
2688-4526
E-ISSN
2688-4526
DOI
10.1002/bco2.441
